Literature DB >> 8882378

Diagnosis and treatment of epilepsy in children and adolescents.

L D Morton1, J M Pellock.   

Abstract

Seizures have a variety of aetiologies and may have various manifestations. Some are recurrent and represent the different types of epilepsy, whereas others are isolated events. Descriptions of various epileptic seizures, as well as their corresponding electroencephalograms (EEGs), have recently led to a unifying international classification of epileptic seizures and epilepsy syndromes. These classifications are extremely important for the practitioner working with the paediatric patient, as they allow for optimal evaluation and treatment. This article reviews the epilepsies and epilepsy syndromes with special attention to age of onset and prognosis. Special circumstances such as status epilepticus, which represents a true medical emergency, are reviewed. The first step in the pharmacological management of seizures is to establish the diagnosis of epilepsy. The recurrence of seizures (or the risk), seizure type and specific syndrome help guide initial treatment choices. There is no drug of choice, but some drugs have proven more effective for certain types of seizure. Monotherapy is preferable, and combination therapy should only be used if monotherapy with first-line drugs fails. Candidates for the newer antiepileptic drugs (e.g. felbamate, gabapentin, lamotrigine and vigabatrin) include patients resistant to older agents or who are unable to tolerate them. The exact place in therapy of these newer agents is uncertain, but in many patients they provide better seizure control and are better tolerated.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8882378     DOI: 10.2165/00003495-199651030-00005

Source DB:  PubMed          Journal:  Drugs        ISSN: 0012-6667            Impact factor:   9.546


  89 in total

1.  The best medicine for febrile seizures.

Authors:  J M Freeman
Journal:  N Engl J Med       Date:  1992-10-15       Impact factor: 91.245

2.  A prospective study of infantile spasms: clinical and therapeutic correlations.

Authors:  C T Lombroso
Journal:  Epilepsia       Date:  1983-04       Impact factor: 5.864

3.  Infantile spasms: I. PET identifies focal cortical dysgenesis in cryptogenic cases for surgical treatment.

Authors:  H T Chugani; W D Shields; D A Shewmon; D M Olson; M E Phelps; W J Peacock
Journal:  Ann Neurol       Date:  1990-04       Impact factor: 10.422

4.  Prognosis of benign childhood epilepsy with centrotemporal spikes: a follow-up study of 168 patients.

Authors:  P Loiseau; B Duché; S Cordova; J F Dartigues; S Cohadon
Journal:  Epilepsia       Date:  1988 May-Jun       Impact factor: 5.864

5.  Occult neonatal seizures.

Authors:  R R Clancy; A Legido; D Lewis
Journal:  Epilepsia       Date:  1988 May-Jun       Impact factor: 5.864

6.  Rectal administration of sodium valproate in status epilepticus.

Authors:  F J Vajda; G W Mihaly; J L Miles; G A Donnan; P F Bladin
Journal:  Neurology       Date:  1978-09       Impact factor: 9.910

Review 7.  Neonatal seizures.

Authors:  M J Painter; I Bergman; P Crumrine
Journal:  Pediatr Clin North Am       Date:  1986-02       Impact factor: 3.278

8.  Status epilepticus in children, adults, and the elderly.

Authors:  R J DeLorenzo; A R Towne; J M Pellock; D Ko
Journal:  Epilepsia       Date:  1992       Impact factor: 5.864

9.  Infantile spasms treated with high doses of sodium valproate: initial response and follow-up.

Authors:  J M Prats; C Garaizar; M J Rua; M L Garcia-Nieto; P Madoz
Journal:  Dev Med Child Neurol       Date:  1991-07       Impact factor: 5.449

10.  Electrographic seizures in preterm and full-term neonates: clinical correlates, associated brain lesions, and risk for neurologic sequelae.

Authors:  M S Scher; K Aso; M E Beggarly; M Y Hamid; D A Steppe; M J Painter
Journal:  Pediatrics       Date:  1993-01       Impact factor: 7.124

View more
  1 in total

1.  Cranial computed tomography in partial motor seizures.

Authors:  Jageer Hussain; S Srinivasan; V Tiroumourougane Serane; S Mahadevan; S Elangovan; V Bhuvaneswari
Journal:  Indian J Pediatr       Date:  2004-07       Impact factor: 1.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.